Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3009 (LINC03009)

Target
LINC03009
Molecular classification
Long non-coding RNA (lncRNA), long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 3009 (LINC03009) is a gene that encodes a long intergenic non-coding RNA, a type of RNA longer than 200 nucleotides that does not overlap protein-coding genes[1][3][5][7]. LINC03009 belongs to the lincRNA class, which are known for regulatory roles in gene expression, including chromatin modification, transcriptional regulation, and RNA stabilization[5][7]. These RNAs tend to be highly tissue-specific and act through diverse molecular mechanisms, although most individual lincRNAs, including LINC03009, remain poorly characterized regarding their explicit biological roles and disease relevance[5][7]. There are currently no known drugs or clinical biomarkers associated specifically with LINC03009, nor is it classified as a therapeutic target[1][3]. If further functional, disease association, or clinical data for LINC03009 becomes available, its profile may be refined accordingly. As of now, it is a valid gene annotation but not a classical drug target.

Other names
LINC03009long intergenic non-protein coding RNA 3009
02

Mechanism of action

None known; lincRNAs may be modulated experimentally by nucleic acid technologies, but no specific mechanisms for drugs targeting LINC03009

03

Biological functions

Regulation of neighboring gene expression (general property of lincRNAs)Chromatin remodelingRNA stabilizationTranscription regulationPotential enhancer-associated activity
04

Disease associations

Other (no direct evidence for involvement of LINC03009 in cancer, inflammation, or other diseases)
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None established

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3009 (LINC03009).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3009 (LINC03009).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call